{"id":"NCT00798707","sponsor":"Pfizer","briefTitle":"Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) in the Treatment of Major Depressive Disorder","officialTitle":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of 2 Fixed Doses (25 and 50 mg/Day) of DVS SR Tablets in Adult Outpatients With Major Depressive Disorder","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-12","primaryCompletion":"2010-04","completion":"2010-04","firstPosted":"2008-11-26","resultsPosted":"2011-06-06","lastUpdate":"2011-06-10"},"enrollment":709,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Major Depressive Disorder"],"interventions":[{"type":"DRUG","name":"Desvenlafaxine Succinate Sustained-Release (DVS SR)","otherNames":[]},{"type":"DRUG","name":"Desvenlafaxine Succinate Sustained-Release (DVS SR)","otherNames":[]},{"type":"DRUG","name":"placebo","otherNames":[]}],"arms":[{"label":"Desvenlafaxine succinate sustained-release 25 mg","type":"EXPERIMENTAL"},{"label":"Desvenlafaxine succinate sustained-release 50 mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The primary purpose of this study is to compare the antidepressant efficacy and safety of two doses of DVS SR (25 and 50 mg/day) in the treatment of adults with Major Depressive Disorder. The study will also assess changes in sexual function and general and functional quality of life outcomes.","primaryOutcome":{"measure":"Change From Baseline in HAM-D17 Total Score at the Final On-therapy (FOT)Evaluation (Week 8 or ET)","timeFrame":"Baseline and Week 8 (or ET)","effectByArm":[{"arm":"Placebo","deltaMin":-8.52,"sd":0.44},{"arm":"DVS SR 25 mg","deltaMin":-8.98,"sd":0.44},{"arm":"DVS SR 50 mg","deltaMin":-10.02,"sd":0.44}],"pValues":[{"comp":"OG000 vs OG001","p":"0.452"},{"comp":"OG000 vs OG002","p":"0.016"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":2},"locations":{"siteCount":78,"countries":["United States","Japan"]},"refs":{"pmids":["34183490","29140227","26709542","26644956","25758058","23334675"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=3151A1-3359&StudyName=Study%20Evaluating%20Desvenlafaxine%20Succinate%20Sustained%20Release%20%28DVS%20SR%29%20in%20the%20Treatment%20of%20Major%20Depressive%20Disorder"]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":231},"commonTop":["Nasopharyngitis","Headache","Nausea","Dizziness","Diarrhoea"]}}